These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 7713103)
21. Losartan: the first angiotensin receptor antagonist in clinical use. Beevers DG J Hum Hypertens; 1995 Nov; 9 Suppl 5():S1. PubMed ID: 8583475 [No Abstract] [Full Text] [Related]
22. Angiotensin receptor antagonists as a treatment for hypertension. MacFadyen RJ; Reid JL J Hypertens; 1994 Dec; 12(12):1333-8. PubMed ID: 7706690 [No Abstract] [Full Text] [Related]
23. Clinical experience with angiotensin II receptor antagonists. Brunner HR; Christen Y; Munafo A; Lee RJ; Waeber B; Nussberger J Am J Hypertens; 1992 Dec; 5(12 Pt 2):243S-246S. PubMed ID: 1290619 [TBL] [Abstract][Full Text] [Related]
24. Losartan: first of a new class of angiotensin antagonists for the management of hypertension. Carr AA; Prisant LM J Clin Pharmacol; 1996 Jan; 36(1):3-12. PubMed ID: 8932538 [TBL] [Abstract][Full Text] [Related]
25. Discovery of losartan, the first angiotensin II receptor antagonist. Timmermans PB; Duncia JV; Carini DJ; Chiu AT; Wong PC; Wexler RR; Smith RD J Hum Hypertens; 1995 Nov; 9 Suppl 5():S3-18. PubMed ID: 8583479 [TBL] [Abstract][Full Text] [Related]
27. Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension. Mallion JM; Goldberg AI Blood Press Suppl; 1996; 2():82-6. PubMed ID: 8913546 [TBL] [Abstract][Full Text] [Related]
28. Clinical experience with the angiotensin II receptor antagonist losartan. A preliminary report. Weber MA Am J Hypertens; 1992 Dec; 5(12 Pt 2):247S-251S. PubMed ID: 1290620 [TBL] [Abstract][Full Text] [Related]
29. [Angiotensin-II receptor blockers]. Metelitsa VI Ter Arkh; 1996; 68(8):64-7. PubMed ID: 9019837 [No Abstract] [Full Text] [Related]
30. Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension. Goa KL; Wagstaff AJ Drugs; 1996 May; 51(5):820-45. PubMed ID: 8861549 [TBL] [Abstract][Full Text] [Related]
31. Losartan and reversible psychosis. Ahmad S Cardiology; 1996; 87(6):569-70. PubMed ID: 8904688 [No Abstract] [Full Text] [Related]
32. Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study. Lacourcière Y; Lefebvre J; Nakhle G; Faison EP; Snavely DB; Nelson EB J Hypertens Suppl; 1994 Jul; 12(2):S49-53. PubMed ID: 7965266 [TBL] [Abstract][Full Text] [Related]
33. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Pitt B; Segal R; Martinez FA; Meurers G; Cowley AJ; Thomas I; Deedwania PC; Ney DE; Snavely DB; Chang PI Lancet; 1997 Mar; 349(9054):747-52. PubMed ID: 9074572 [TBL] [Abstract][Full Text] [Related]
34. The clinical efficacy and tolerability of the angiotensin II-receptor antagonist losartan in Japanese patients with hypertension. Ogihara T; Yoshinaga K Blood Press Suppl; 1996; 2():78-81. PubMed ID: 8913545 [TBL] [Abstract][Full Text] [Related]
35. The diversified pharmacology of angiotensin II-receptor blockade. Timmermans PB; Smith RD Blood Press Suppl; 1996; 2():53-61. PubMed ID: 8913541 [TBL] [Abstract][Full Text] [Related]
36. Angiotensin II receptor antagonists, elite drugs (or not) for patients with heart failure or hypertension? Beevers DG; Lip GY J Hum Hypertens; 1997 Jun; 11(6):329-30. PubMed ID: 9249225 [No Abstract] [Full Text] [Related]
37. Losartan: a new antihypertensive drug. Dubois M; Wilson TW Can Nurse; 1997 Jun; 93(6):31-4. PubMed ID: 9233121 [TBL] [Abstract][Full Text] [Related]
38. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension. Lacourcière Y Can J Cardiol; 1995 Aug; 11 Suppl F():45F-48F. PubMed ID: 7664218 [TBL] [Abstract][Full Text] [Related]
39. [Angiotensin II antagonists]. Tikkanen I; Tikkanen T Duodecim; 1995; 111(18):1733-5. PubMed ID: 9340266 [No Abstract] [Full Text] [Related]